Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
UroGen Pharma (URGN) Forecast
NewsEarningsUroGen Pharma (URGN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
UroGen Pharma Stock Price, Quotes and Forecasts | NASDAQ:URGN | Benzinga
Explore UroGen Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for URGN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy UroGen Pharma (URGN) stock?
You can purchase shares of UroGen Pharma (NASDAQ:URGN) through any online brokerage.
Who are UroGen Pharma (URGN) competitors?
There are no as such competitors for UroGen Pharma.
What is the forecast, or price target, for UroGen Pharma (URGN) stock?
UroGen Pharma has a consensus price target of $32.65.
What is the current price for UroGen Pharma (URGN)?
The stock price for UroGen Pharma (NASDAQ: URGN) is $10.095 last updated March 5, 2025 at 12:52 PM EST.
Does UroGen Pharma (URGN) pay a dividend?
There are no upcoming dividends for UroGen Pharma.
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is UroGen Pharma (URGN) going to split?
There is no upcoming split for UroGen Pharma.
What sector and industry does UroGen Pharma (URGN) operate in?
UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.